Literature DB >> 2088197

Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice.

G Samonis1, E J Anaissie, G P Bodey.   

Abstract

Male Crl:CD1 (ICR) BR mice, 3 months old, were fed regular chow or chow containing Candida albicans. Subsequently, both groups were treated with either antibiotics or normal saline for 10 days. Stool cultures were obtained to determine the extent of C. albicans colonization immediately before treatment, at the end of treatment, and 1 week after the discontinuation of treatment. Animals in the antibiotic-treated groups had substantially higher Candida counts than control animals fed C. albicans, especially if they received ceftriaxone, cefoperazone, or ticarcillin-clavulanic acid. There was no evidence of Candida dissemination to internal organs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088197      PMCID: PMC172073          DOI: 10.1128/AAC.34.12.2420

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology.

Authors:  R L Myerowitz; G J Pazin; C M Allen
Journal:  Am J Clin Pathol       Date:  1977-07       Impact factor: 2.493

2.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

Authors:  E J Freireich; E A Gehan; D P Rall; L H Schmidt; H E Skipper
Journal:  Cancer Chemother Rep       Date:  1966-05

3.  Candida sepsis: pathogenesis and principles of treatments.

Authors:  H H Stone; L D Kolb; C A Currie; C E Geheber; J Z Cuzzell
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

4.  A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice.

Authors:  G Samonis; E J Anaissie; B Rosenbaum; G P Bodey
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.

Authors:  S R Norrby; K Alestig; F Ferber; J L Huber; K H Jones; F M Kahan; M A Meisinger; J D Rogers
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

6.  Biliary excretion and pharmacokinetics of cefoperazone in humans.

Authors:  B Kemmerich; H Lode; K Borner; D Belmega; T Jendroschek; P Koeppe; G Goertz
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

7.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

8.  Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers.

Authors:  H G de Vries-Hospers; G W Welling; E A Swabb; D van der Waaij
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

9.  Impact of imipenem/cilastatin therapy on faecal flora.

Authors:  C E Nord; L Kager; A Philipson; G Stiernstedt
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

10.  Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

View more
  19 in total

1.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy.

Authors:  Katie L Mason; John R Erb Downward; Kelly D Mason; Nicole R Falkowski; Kathryn A Eaton; John Y Kao; Vincent B Young; Gary B Huffnagle
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

3.  The Role of the Intestinal Tract As a Source for Transmission of Nosocomial Pathogens.

Authors:  Usha Stiefel; Curtis J Donskey
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

4.  Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice.

Authors:  Nicole J Pultz; Usha Stiefel; Mahmoud Ghannoum; Marion S Helfand; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.

Authors:  Karl V Clemons; Gloria M Gonzalez; Gaurav Singh; Jackie Imai; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 6.  Inflammation and gastrointestinal Candida colonization.

Authors:  Carol A Kumamoto
Journal:  Curr Opin Microbiol       Date:  2011-07-28       Impact factor: 7.934

7.  Gastrointestinal colonization by methicillin-resistant Staphylococcus aureus in immunosuppressed mice.

Authors:  N Kato-Matsunaga; K Okonogi
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 8.  Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.

Authors:  J L Vincent; E Anaissie; H Bruining; W Demajo; M el-Ebiary; J Haber; Y Hiramatsu; G Nitenberg; P O Nyström; D Pittet; T Rogers; P Sandven; G Sganga; M D Schaller; J Solomkin
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

9.  Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.

Authors:  Yun-Gi Kim; Kankanam Gamage Sanath Udayanga; Naoya Totsuka; Jason B Weinberg; Gabriel Núñez; Akira Shibuya
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

10.  Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans.

Authors:  G Samonis; H Anastassiadou; M Dassiou; Y Tselentis; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.